Toon van der Gronde
-
- Viral-associated cancers and disorders 3
- Lung Cancer Research Studies 2
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 4
- Gastric Cancer Management and Outcomes 3
-
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Lymphoma Diagnosis and Treatment 3
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- Toine PietersCarin A. Uyl‐de GrootOlivier de HonHidde J. HaismaAnita HartogMustafa ÖzgüroğluSuresh S. RamalingamShun Lü
- Partner nations
- United StatesNetherlandsUnited Kingdom
In The Last Decade
Toon van der Gronde
22 papers receiving 345 citations
Peers
Comparison fields: 5 of 100
- Chemical Health and Safety 3
- Oncology 87
- Pulmonary and Respiratory Medicine 97
- Economics and Econometrics 62
- Pharmacology 18
Countries citing papers authored by Toon van der Gronde
This map shows the geographic impact of Toon van der Gronde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toon van der Gronde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toon van der Gronde more than expected).
Fields of papers citing papers by Toon van der Gronde
This network shows the impact of papers produced by Toon van der Gronde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toon van der Gronde. The network helps show where Toon van der Gronde may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toon van der Gronde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 11 | |
| 4 | 2024 | 5 | |
| 5 | 2021 | 43 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 6 | |
| 8 | 2018 | 3 | |
| 9 | Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags. | 2018 | 5 |
| 10 | 2017 | 83 | |
| 11 | 2017 | 2 | |
| 12 | 2017 | 7 | |
| 13 | 2017 | 10 | |
| 14 | 2017 | 26 | |
| 15 | 2016 | 8 | |
| 16 | 2016 | 15 | |
| 17 | 2015 | 36 | |
| 18 | 2015 | 8 | |
| 19 | 2014 | 22 | |
| 20 | 2013 | 29 |
About Toon van der Gronde
Toon van der Gronde is a scholar working on Biological Psychiatry, Oncology and Geriatrics and Gerontology, having authored 22 papers that have together received 353 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (3 papers), Gastric Cancer Management and Outcomes (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Lung Cancer Research Studies (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Chemical Health and Safety (3 citations), Oncology (87 citations) and Pulmonary and Respiratory Medicine (97 citations). Toon van der Gronde has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Toine Pieters, Carin A. Uyl‐de Groot, Olivier de Hon, Hidde J. Haisma, Anita Hartog, Mustafa Özgüroğlu, Suresh S. Ramalingam, Shun Lü, Terufumi Kato and Satish Gopal. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.